Description
Venetoclax belongs to a category of drugs known as B-cell lymphoma-2 (BCL-2) inhibitors.
Its mechanism of action involves blocking the activity of a specific protein in the body that aids cancer cells in survival. By inhibiting this protein, Venetoclax assists in inducing cancer cell death.
